The valuation really doesn't take into consideration the actual yearly revenue potential of FTO and Cardioprotection and then a premium for a buyout figure.
Consider Immunomedics buyout at $21bn in RAC terms that's $123.50.
Are we worth that? It depends who you ask I suppose, but we are worth a hell of a lot more than even $11.
The valuation really doesn't take into consideration the actual...
-
- There are more pages in this discussion • 8,282 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.000(0.00%) |
Mkt cap ! $289.7M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.70 | $1.65 | $100.0K | 59.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 601 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 4823 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |